10 million doses from India won't impact poor nations' vaccine access, says UK

The minister in charge of overseeing the UK's vaccination programme said the vaccine doses developed by the Serum Institute of India, in collaboration with Oxford/AstraZeneca, were always intended for Britain and that assurances have been sought that the delivery would not impact other supplies.

from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/3cbaCHk